Amicus Therapeutics
FOLD
#3916
Rank
A$4.57 B
Marketcap
A$14.84
Share price
-0.51%
Change (1 day)
-3.41%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2025 (TTM): A-$0.17

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$0.17. In 2014 the company made an earnings per share (EPS) of A-$1.40.

EPS history for Amicus Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.17
2014A-$1.40
2012A-$1.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
A$16.55-10,090.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.10-2,572.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.81 390.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.42-3,369.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A-$0.29 72.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$5.29-3,294.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark